Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Journal of Clinical Apheresis|January 1, 1997
Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignanciesJ Mehta, R Powles, J Treleaven, et al.
Leukemia & Lymphoma|July 1, 1992
Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantationC Tiley, R Powles, J Catalano, et al.
Bone Marrow Transplantation|June 12, 2002
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?J Mehta, R Powles, B Sirohi, et al.
Leukemia & Lymphoma|March 1, 1994
Cimetidine-induced myelosuppression after bone marrow transplantationJ Mehta, R L Powles, J Treleaven, et al.
Rheumatology (Oxford, England)|September 25, 2007
Conservative treatments for tennis elbow do subgroups of patients respond differently?L Bisset, N Smidt, D A Van der Windt, et al.
Leukemia & Lymphoma|September 24, 1999
The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapyJ Mehta, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|July 3, 2003
Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?J Mehta, R Powles, B Sirohi, et al.
Bone Marrow Transplantation|April 1, 1996
Central nervous system relapse after bone marrow transplantation for acute leukemia in first remissionS Singhal, R Powles, J Treleaven, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha2bB Sirohi, R Powles, D Lawrence, et al.
Bone Marrow Transplantation|October 1, 1995
Kinetics of paraprotein clearance after autografting for multiple myelomaS Singhal, R Powles, S Milan, et al.
Pageof 19